A reversible condition wherein large vacuoles of triglyceride fat accumulate in liver cells via the process of steatosis.
Comprehensive, easy-to-understand information about this condition
How we create this content →Report Generation Failed
We couldn't automatically generate the report. This may be due to temporary service issues.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning fatty liver disease
Updated Feb 4, 2026
Recent research identifies TRIB1AL as a potential target for steatotic liver disease through integrative genetic and liver transcriptomic analyses. This discovery could pave the way for new therapeutic strategies in managing this condition.
A recent case study highlights pseudohyponatremia in a patient with severe liver disease, shedding light on the complexities of electrolyte imbalances in this population. This finding may influence clinical approaches to managing sodium levels in patients with liver conditions.